We think the PacBio Sequel II should force a giant change in how people approach routine sequencing work. In the past, the usual progression was to do the bulk of sequencing with Illumina short reads, then improve the contiguity of the assembly with PacBio. The Sequel II has dramatically lower costs and we think many sequencing projects should start and end with PacBio long reads. See our projects page for examples and pricing: https://www.snpsaurus.com/pacbio-small-genome-assembly/
-
Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...